A new tool for better early detection of melanoma
Fast, large area, multiphoton exoscope (FLAME) for improving early detection of melanoma
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA-IRVINE · NIH-10914116
This study is testing a new imaging tool called FLAME that helps doctors spot melanoma, a serious skin cancer, more accurately and quickly, so patients can get better care without unnecessary procedures.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA-IRVINE (nih funded) |
| Locations | 1 site (IRVINE, UNITED STATES) |
| Trial ID | NIH-10914116 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a fast, large area multiphoton exoscope (FLAME) to improve the early detection of melanoma, a serious skin cancer. By using advanced imaging technology, the FLAME aims to provide more accurate, non-invasive assessments of skin lesions compared to traditional dermoscopy, which can often lead to false negatives. The goal is to enhance diagnostic accuracy, reduce unnecessary biopsies, and ultimately improve patient outcomes. The research will involve clinical evaluations to assess the effectiveness of this new imaging tool in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with suspicious skin lesions that may be melanoma or other melanocytic neoplasms.
Not a fit: Patients with confirmed melanoma or those without any skin lesions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of melanoma, improving survival rates and reducing treatment costs for patients.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for skin cancer detection, suggesting that this approach may lead to significant advancements in melanoma diagnosis.
Where this research is happening
IRVINE, UNITED STATES
- UNIVERSITY OF CALIFORNIA-IRVINE — IRVINE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BALU, MIHAELA — UNIVERSITY OF CALIFORNIA-IRVINE
- Study coordinator: BALU, MIHAELA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.